Noncoding RNAs as novel immunotherapeutic tools against cancer.

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Advances in Protein Chemistry and Structural Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/bs.apcsb.2021.11.011PMID 35305717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noncoding RNA therapeutics — challenges and potential solutions

  2021cited by this paper
• The Research Progress in Immunotherapy of Tuberculosis

  2021cited by this paper
• A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers

  2021cited by this paper
• Targeting macrophages in cancer immunotherapy

  2021cited by this paper
• miRNA Expression Profile in the N2 Phenotype Neutrophils of Colorectal Cancer and Screen of Putative Key miRNAs

  2020cited by this paper
• RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription

  2020cited by this paper
• Noncoding RNAs: the shot callers in tumor immune escape

  2020cited by this paper
• Long noncoding RNA: a dazzling dancer in tumor immune microenvironment

  2020cited by this paper
• Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression

  2020cited by this paper
• FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.

  2020cited by this paper
• Breast cancer-derived exosomes transmit lncRNA SNHG16 to induce CD73+γδ1 Treg cells

  2020cited by this paper
• Tumor-Associated Macrophages: Recent Insights and Therapies

  2020cited by this paper
• Long non-coding RNA X-inactive specific transcript silencing ameliorates primary graft dysfunction following lung transplantation through microRNA-21-dependent mechanism

  2020cited by this paper
• lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer

  2020cited by this paper
• LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis

  2020cited by this paper
• MicroRNAs: As Critical Regulators of Tumor- Associated Macrophages

  2020cited by this paper
• Human immunology and immunotherapy: main achievements and challenges

  2020cited by this paper
• Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma

  2020cited by this paper
• LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.

  2019cited by this paper
• Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC

  2019cited by this paper
• LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3

  2019cited by this paper
• Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.

  2019cited by this paper
• LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.

  2019cited by this paper
• Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype

  2019cited by this paper
• IFNG-AS1 Enhances Interferon Gamma Production in Human Natural Killer Cells

  2019cited by this paper
• Adjunctive Immunotherapeutic efficacy of an N-formylated internal peptide of mycobacterial glutamine synthetase in mouse model of tuberculosis.

  2019cited by this paper
• Long Noncoding RNA GM16343 Promotes IL-36β to Regulate Tumor Microenvironment by CD8+T cells

  2019cited by this paper
• TCF-4 Regulated lncRNA-XIST Promotes M2 Polarization Of Macrophages And Is Associated With Lung Cancer

  2019cited by this paper
• LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint

  2019cited by this paper
• Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils

  2019cited by this paper
• Long non‐coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B‐cell lymphoma cells by targeting miR‐497‐5p/PIM1 axis

  2019cited by this paper
• An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme

  2019cited by this paper
• GNAS-AS1/miR-4319/NECAB3 axis promotes migration and invasion of non-small cell lung cancer cells by altering macrophage polarization

  2019cited by this paper
• Silencing of lncRNA MALAT1 Prevents Inflammatory Injury after Lung Transplant Ischemia-Reperfusion by Downregulation of IL-8 via p300

  2019cited by this paper
• PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells

  2019cited by this paper
• Oncogenic LncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

  2019cited by this paper
• MiR-218-5p Suppresses the Killing Effect of Natural Killer Cell to Lung Adenocarcinoma by Targeting SHMT1

  2019cited by this paper
• NK cells to cure cancer.

  2019cited by this paper
• Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?

  2019cited by this paper
• Manufacturing history of etanercept (Enbrel®): Consistency of product quality through major process revisions

  2018cited by this paper
• MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages

  2018cited by this paper
• Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC

  2018cited by this paper
• CRISPR/Cas9-mediated noncoding RNA editing in human cancers

  2018cited by this paper
• microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.

  2018cited by this paper
• Transfer of miRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma.

  2018cited by this paper
• Long non‐coding RNA CCAT1/miR‐148a/PKCζ prevents cell migration of prostate cancer by altering macrophage polarization

  2018cited by this paper
• NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death

  2018cited by this paper
• NKX2-1-AS1 negatively regulates CD274/PD-L1, cell-cell interaction genes, and limits human lung carcinoma cell migration

  2018cited by this paper
• Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H

  2018cited by this paper
• Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer

  2018cited by this paper
• Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells

  2018cited by this paper
• Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious Diseases

  2018cited by this paper
• Antitumor immunity is defective in T cell–specific microRNA-155–deficient mice and is rescued by immune checkpoint blockade

  2017cited by this paper
• Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells

  2017cited by this paper
• Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway

  2017cited by this paper
• LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy

  2017cited by this paper
• Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells

  2017cited by this paper
• The Future of Immunotherapy: A 20-Year Perspective

  2017cited by this paper
• The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma.

  2017cited by this paper
• Towards personalized, tumour-specific, therapeutic vaccines for cancer

  2017cited by this paper
• Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR‐138 targets TERT and PD‐L1

  2017cited by this paper
• NK Cell Exhaustion

  2017cited by this paper
• Long Noncoding RNA and Cancer: A New Paradigm.

  2017cited by this paper
• Markers and function of human NK cells in normal and pathological conditions

  2017cited by this paper
• miRNA-10b sponge: An anti-breast cancer study in vitro

  2016cited by this paper
• Sponges against miR-19 and miR-155 reactivate the p53-Socs1 axis in hematopoietic cancers.

  2016cited by this paper
• Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

  2016cited by this paper
• Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer

  2016cited by this paper
• Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma.

  2016cited by this paper
• B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation.

  2016cited by this paper
• miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion

  2016cited by this paper
• A long noncoding RNA positively regulates CD56 in human natural killer cells

  2016cited by this paper
• miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint

  2016cited by this paper
• Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

  2016cited by this paper
• Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma.

  2016cited by this paper
• Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems

  2016cited by this paper
• MicroRNA-491 regulates the proliferation and apoptosis of CD8+ T cells

  2016cited by this paper
• MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.

  2016cited by this paper
• Dendritic cell-based immunotherapy

  2016cited by this paper
• MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma.

  2016cited by this paper
• BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia

  2015cited by this paper
• LncRNA Expression Discriminates Karyotype and Predicts Survival in B-Lymphoblastic Leukemia

  2015cited by this paper
• Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia.

  2015cited by this paper
• Monocytes and macrophages: developmental pathways and tissue homeostasis

  2014cited by this paper
• TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells

  2014cited by this paper
• Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.

  2014cited by this paper
• Immunotherapeutic potential of N-formylated peptides of ESAT-6 and glutamine synthetase in experimental tuberculosis.

  2014cited by this paper
• MicroRNAs, Major Players in B Cells Homeostasis and Function

  2014cited by this paper
• Immunotherapeutic potential of recombinant ESAT-6 protein in mouse model of experimental tuberculosis.

  2014cited by this paper
• MicroRNA-150 regulates the cytotoxicity of natural killers by targeting perforin-1.

  2014cited by this paper
• Integrated mRNA-MicroRNA Profiling of Human NK Cell Differentiation Identifies MiR-583 as a Negative Regulator of IL2Rγ Expression

  2014cited by this paper
• MicroRNA-155 Tunes Both the Threshold and Extent of NK Cell Activation via Targeting of Multiple Signaling Pathways

  2013cited by this paper
• Oncology meets immunology: the cancer-immunity cycle.

  2013cited by this paper
• Identification of Resting and Type I IFN-Activated Human NK Cell miRNomes Reveals MicroRNA-378 and MicroRNA-30e as Negative Regulators of NK Cell Cytotoxicity

  2012cited by this paper
• TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.

  2012cited by this paper
• LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas.

  2012cited by this paper
• Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity.

  2011cited by this paper
• Suicide Gene Therapy to Increase the Safety of Chimeric Antigen Receptor-Redirected T Lymphocytes

  2011cited by this paper
• Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation.

  2011cited by this paper
• Developing therapeutic microRNAs for cancer

  2011cited by this paper

• Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies

  2024cites this paper
• The regulatory roles of RNA-binding proteins in the tumour immune microenvironment of gastrointestinal malignancies

  2024cites this paper
• Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications

  2023cites this paper
• Epigenetic modifications: Critical participants of the PD-L1 regulatory mechanism in solid tumors (Review)

  2022cites this paper
• A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer

  2022cites this paper